Skip to content
Screener

Neogen NEOG Operating Cash Flow

Operating Cash Flow at other companies

Thermo Fisher Scientific logo
Thermo Fisher ScientificTMO
$2.13B+51.9%
Idexx Laboratories logo
Idexx LaboratoriesIDXX
$347.16M+86.9%
Zoetis logo
ZoetisZTS
$655M+8.3%
Revvity logo
RevvityRVTY
$115.23M-10.1%
Merck & Co. logo
Merck & Co.MRK
$5.37B+63.1%
TEC
Bio-TechneTECH
$86.66M+111%

Other financials

Income statement

See full
Revenue$211.2M-4.4%
Gross profit$99.0M-10.2%
Operating income-$3.3M-161%
Net income-$17.0M-56.0%
EPS (diluted)-$0.08-60.0%

Balance sheet

See full
Cash & equivalents$159.9M+25.2%
Total debt$793.3M-11.2%
Total equity$2.1B-21.0%
Total assets$3.4B-16.8%

Cash flow

See full
CapEx$11.6M-64.7%
Free cash flow$11.1M+182%

Valuation

See full
Market cap$2.46B+138%
Enterprise value$3.1B+70.0%
P/S2.8×+1.7×

Profitability

See full
Gross margin45.2%-3.6pp
Operating margin-73.1%+77.7pp
Net margin-69.9%+30.8pp
FCF margin-14%

Returns & leverage

See full
Return on equity-25.6%+28.8pp
Debt / equity0.4×0.0×
Current ratio3.9×0.0×

Where this comes from

Reported directly by Neogen in its filing.

Tagged under the XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities.

The source filing: Neogen’s 10-Q, filed April 9, 2026.

Filed
Apr 9, 2026, 4:03 PM EDT
Fiscal quarter
Q3 FY2026
Calendar quarter
Q1 2026
Accession
0001193125-26-149599
Line itemNine months ended February 28, 2026Nine months ended February 28, 2025
Accounts payable and accrued liabilities20.56.0
Interest expense accrual(7.6)(7.5)
Change in other non-current assets and non-current liabilities0.33.2
Net Cash provided by Operating Activities53.041.8
Cash Flows provided by (used for) Investing Activities
Purchases of property, equipment and intangible assets(47.3)(88.5)
Proceeds from the maturities of marketable securities0.3
Proceeds from sale of business, net of cash divested121.7

Item 1. Interim Condensed Consolidated Financial Statements

FAQ

What is Neogen's operating cash flow?
Neogen (NEOG) reported operating cash flow of $22.7M in Q4 2025.
How has Neogen's operating cash flow changed year-over-year?
Neogen's operating cash flow increased by 16.7% year-over-year, from $19.46M to $22.7M.
What is the long-term trend for Neogen's operating cash flow?
Over 2 years (2022 to 2025), Neogen's operating cash flow has grown at a -7.5% compound annual growth rate (CAGR), from $68.04M to $58.24M.
What does operating cash flow mean?
Total cash generated by or used in core business operations — the single most important cash flow metric for assessing business health.

Ask your AI about Neogen's operating cash flow.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude